Target intelligence / Profile preview

Peptidase and hydrolase enzyme orthosteric active sites

Molecular classification
Enzyme, Hydrolase, Peptidase
01

Overview

The orthosteric active sites of peptidases and hydrolases represent the primary catalytic regions where substrates bind and undergo chemical transformation via the addition of water. Peptidases, a major subclass of hydrolases, specifically target peptide bonds, playing critical roles in protein turnover, signaling, and digestion (nih.gov, 1.1.2, 1.1.3). These sites are characterized by specific catalytic residues, such as the serine-histidine-aspartate triad or metal ions like zinc, which facilitate the nucleophilic attack on the substrate (nih.gov, 1.3.3, 1.4.1). In pharmacology, these sites are among the most successful therapeutic targets, with drugs designed to mimic the transition state or covalently bind to catalytic residues to block activity (nih.gov, 1.2.1, 1.4.3). However, the high degree of structural conservation within enzyme families often poses significant challenges for achieving high selectivity, leading to potential off-target effects and therapeutic challenges (nih.gov, 1.2.5, 1.3.1). Consequently, while these sites are highly druggable, the term describes a broad class of structural features across thousands of different enzymes rather than a single specific therapeutic target (nih.gov, 1.2.4).

Other names
Protease active sitesCatalytic triadsHydrolase pocketsOrthosteric catalytic sitesEnzyme active sites
02

Mechanism of action

Competitive inhibition at the orthosteric site, often involving transition-state mimicry or covalent modification of catalytic residues to block substrate binding and catalysis.

03

Biological functions

ProteolysisHydrolysisMetabolismSignal transductionProtein turnoverDigestionCell homeostasis
04

Disease associations

HypertensionDiabetesViral infectionCancerInflammationCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Off-target effects due to high active site homology within enzyme familiesLack of selectivity among related family membersPotential for toxicity from broad-spectrum inhibitionCovalent inhibitor reactivity with non-target nucleophiles
06

Interacting drugs

Lisinopril

7 more in the full profile.

07

Biomarkers

Enzyme activity levelsSubstrate cleavage productsAngiotensin II levelsBlood glucose levelsViral load

Beyond the preview

Go deeper on Peptidase and hydrolase enzyme orthosteric active sites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidase and hydrolase enzyme orthosteric active sites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call